SEARLE & CO. - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 36 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2018. The put-call ratio across all filers is 3.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEARLE & CO. ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2018$13,000
-59.4%
13,200
-0.9%
0.01%
-60.0%
Q2 2018$32,0000.0%13,3250.0%0.02%
-4.8%
Q1 2018$32,0000.0%13,3250.0%0.02%
+5.0%
Q4 2017$32,000
-40.7%
13,325
-22.8%
0.02%
-44.4%
Q3 2017$54,000
-21.7%
17,2500.0%0.04%
-23.4%
Q2 2017$69,000
+7.8%
17,2500.0%0.05%
+4.4%
Q1 2017$64,00017,2500.04%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
IFP Advisors, Inc 427$2,0000.00%
Advisor Group, Inc. 177$1,0000.00%
BANK OF AMERICA CORP /DE/ 8,363$31,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders